Target intelligence / Profile preview

Drosha–DGCR8 microprocessor complex (Microprocessor) (Microprocessor)

Target
Microprocessor
Molecular classification
Enzyme, Ribonuclease, RNA-binding protein complex
01

Overview

The Drosha–DGCR8 microprocessor complex is a nuclear heterotrimeric assembly essential for the primary step of microRNA (miRNA) biogenesis (NIH, 2020). It consists of one molecule of the Class 2 ribonuclease III enzyme Drosha and two molecules of the RNA-binding protein DGCR8 (DiGeorge syndrome critical region 8) (Wikipedia, 2024). Within the complex, DGCR8 acts as a molecular anchor and ruler, recognizing the junction between the single-stranded and double-stranded regions of primary miRNA (pri-miRNA) transcripts and positioning Drosha to execute a precise endonucleolytic cleavage (UniProt, 2024). This process releases a ~70-nucleotide precursor miRNA (pre-miRNA) hairpin, which is subsequently exported to the cytoplasm for further maturation by Dicer (PubMed, 2011). Beyond miRNA processing, the complex regulates the stability of various messenger RNAs (mRNAs) and small nucleolar RNAs (snoRNAs), often through an auto-regulatory feedback loop where it cleaves its own components' transcripts (NIH, 2012). Dysregulation of the microprocessor complex is linked to numerous pathologies, including various cancers where it can act as either an oncogene or a tumor suppressor, and DiGeorge syndrome, which is characterized by the deletion of the DGCR8 gene (MDPI, 2024). Therapeutic strategies targeting the complex include small molecule inhibitors like acriflavine and enhancers like enoxacin, aimed at modulating miRNA-mediated gene silencing in disease contexts (PubMed, 2019).

Other names
Microprocessor complexDrosha-DGCR8 complexPasha-Drosha complexRNASEN-DGCR8 complex
02

Mechanism of action

Inhibition of endonucleolytic cleavage, enhancement of miRNA processing, and disruption of protein-protein or protein-RNA interactions.

03

Biological functions

microRNA biogenesisRNA processingGene expression regulationmRNA stabilityAlternative splicing
04

Disease associations

CancerDiGeorge syndromeInfectionCardiovascular disease
05

Safety considerations

Global miRNA dysregulationEmbryonic lethalityOff-target effects on non-canonical RNA substrates
06

Interacting drugs

Acriflavine

6 more in the full profile.

07

Biomarkers

DGCR8 mRNA expressionDrosha protein expressionmiRNA expression signatures

Beyond the preview

Go deeper on Drosha–DGCR8 microprocessor complex (Microprocessor) (Microprocessor).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Drosha–DGCR8 microprocessor complex (Microprocessor) (Microprocessor).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call